166 filings
Page 5 of 9
6-K
m0iy47ba6ujw2o s2r
9 Apr 19
Galmed Pharmaceuticals Announces Successful Completion of
8:10am
6-K
qt24gn dqag6
4 Apr 19
Current report (foreign)
4:31pm
6-K
b6c60 ssk
13 Mar 19
Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
7:23am
6-K
pcbofxsf0ko9vurb
12 Mar 19
Galmed Reports Positive Results from Pharmacokinetic
8:14am
6-K
rbkypy39aelq g3u
26 Dec 18
Current report (foreign)
8:00am
6-K
47nod79w7w d7
14 Nov 18
Current report (foreign)
4:30pm
6-K
4yejeerh 1ro
5 Nov 18
Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results
7:00am
6-K
tczoyooq2qos16wg
16 Oct 18
Current report (foreign)
4:30pm
6-K
p33hf
30 Aug 18
Current report (foreign)
12:00am
6-K
dtehmvo xo9s
2 Aug 18
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2018 Financial Results
7:01am
6-K
nrm 3wnenf8
19 Jul 18
Current report (foreign)
5:21pm
6-K
ekfc6t
21 Jun 18
Current report (foreign)
4:19pm
6-K
ttvedf15
18 Jun 18
Current report (foreign)
6:35am
6-K
j3sol
12 Jun 18
Galmed’s 600 mg AramcholTM Achieved a Regulatory Approvable Endpoint Showing NASH
7:00am
6-K
fn0gml6c9erfg
9 May 18
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results
7:00am
6-K
3hcw8518xz799z i6
4 Apr 18
Current report (foreign)
12:00am
6-K
0k0kgx0zb1nclru
3 Apr 18
Galmed Pharmaceuticals Announces Pricing of $6.0 Million Registered Direct Offering
12:00am
6-K
sncjavko7 8f
13 Mar 18
Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
12:00am
6-K
8nnl 56cth
14 Feb 18
Galmed Announces ARRIVE Study Data
12:00am
6-K
iwdakq7flnewp8
7 Feb 18
Galmed Granted "Preferred Technological Enterprise" Status Which
12:00am